Ethicon, Inc.

- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1992-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ethicon.com
The EVICEL® Neurosurgery Phase III Study
- Conditions
- Cerebrospinal Fluid Leak
- First Posted Date
- 2015-05-29
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 234
- Registration Number
- NCT02457546
- Locations
- 🇺🇸
Clinical Investigation Site #27, Los Angeles, California, United States
🇺🇸Clinical Investigation Site #17, Sacramento, California, United States
🇺🇸Clinical Investigation Site #18, Jacksonville, Florida, United States
The Paediatric EVICEL® Neuro Study
- Conditions
- CSF Leak
- First Posted Date
- 2014-12-05
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02309645
- Locations
- 🇬🇧
Clinical Investigation Site #24, Edinburgh, United Kingdom
🇬🇧Clinical Investigation Site #22, Leeds, United Kingdom
🇬🇧Clinical Investigation Site #21, Liverpool, United Kingdom
The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding Study
- Conditions
- Soft Tissue BleedingHemorrhage
- First Posted Date
- 2014-08-28
- Last Posted Date
- 2020-08-31
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02227706
- Locations
- 🇧🇪
Clinical Investigation Site #31, Brussels, Belgium
🇨🇦Clinical Investigation Site #42, Hamilton, Ontario, Canada
🇨🇦Clinical Investigation Site #40, Toronto, Ontario, Canada
The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study
- Conditions
- HemorrhageSoft Tissue BleedingHepatic Parenchyma Bleeding
- First Posted Date
- 2014-08-28
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02227992
- Locations
- 🇧🇪
Clinical Investigation Site #32, Brussels, Belgium
🇧🇪Investigative Site #30, Genk, Belgium
🇧🇪Clinical Investigation Site #31, Gent, Belgium
The Bioseal Vascular Study
- Conditions
- Vascular BleedingCardiovascular BleedingHemorrhage
- First Posted Date
- 2014-03-24
- Last Posted Date
- 2018-03-08
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 252
- Registration Number
- NCT02094885
- Locations
- 🇨🇳
Clinical Investigation Site #21, Guangzhou City, Guangdong, China
🇨🇳Clinical Investigation Site #32, Nanjing, Jiangsu, China
🇨🇳Clinical Investigation Site #31, Nanjing, Jiangsu, China
The Fibrin Pad CV Phase III Study
- Conditions
- Cardiovascular Disease
- First Posted Date
- 2014-01-20
- Last Posted Date
- 2017-08-15
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT02040428
- Locations
- 🇺🇸
Clinical Investigation Site #15, Atlanta, Georgia, United States
🇺🇸Clinical Investigation Site #14, Indianapolis, Indiana, United States
🇺🇸Clinical Investigation Site #16, Baltimore, Maryland, United States
Phase IV Bioseal Study in Brain Tumor Surgery
- Conditions
- HemostasisMeningioma Surgery
- First Posted Date
- 2014-01-14
- Last Posted Date
- 2018-02-26
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 256
- Registration Number
- NCT02034799
- Locations
- 🇨🇳
Clinical Investigation Site #6, Zhengzhou, Henan, China
🇨🇳Clinical Investigation Site #5, Changsha, Hunan, China
🇨🇳Clinical Investigation Site #3, Chengdu, Sichuan, China
The EVARREST® Fibrin Sealant Patch Liver Study
- Conditions
- Hemorrhage
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT01993888
- Locations
- 🇺🇸
Clinical Investigation Site #13, Birmingham, Alabama, United States
🇺🇸Clinical Investigation Site #10, Augusta, Georgia, United States
🇺🇸Clinical Investigation Site #16, Chicago, Illinois, United States
EVARREST™ Fibrin Sealant Patch Post-Market Study
- Conditions
- HemorrhageSoft Tissue Bleeding
- First Posted Date
- 2013-07-18
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT01902459
- Locations
- 🇺🇸
Clinical Site #10, Saint Louis, Missouri, United States
Occipital Nerve Stimulation in the Treatment of Migraine
- Conditions
- Migraine
- First Posted Date
- 2013-05-16
- Last Posted Date
- 2013-07-17
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT01855672
- Locations
- 🇺🇸
ActivMed, Newington, New Hampshire, United States
🇺🇸Clinilabs, New York, New York, United States
🇺🇸Community Research, Cincinnati, Ohio, United States